Body Contouring

Many men and women suffer from unwanted cellulite, stretch marks and stubborn body fat that is resistant to diet and exercise and other means of weight loss.  When these methods fail, stubborn problem areas can persist and until recently, the only option was painful and expensive surgery.

However, there is an effective and safer way to treat these conditions and at much less cost.  VelaShape is an FDA-approved body contouring treatment that utilizes revolutionary elos technology. By combining Bi-Polar Radiofrequency (RF), Infrared Light Energy, plus Vacuum and Mechanical Massage, unwanted fat can be targeted and reduced on the body.  The procedure also evens out the skin, making it smoother and tighter.

The combination therapy has been proven in clinical trials to be safe and effective.  In fact, Velashape is the only non-surgical method cleared by the FDA for circumferential fat reduction.  Gradual changes can be seen after the first treatment, with best results seen after a series of treatments has been completed.  The most benefit can often be noticed 6-8 weeks after the final session.  Any body area can be treated, although most people prefer to target the thighs, buttocks, abdomen, love handles and neck.

In clinical trials, an average of 1 inch of fat reduction was noted, with up to 3 inches of circumferential fat reduction being reported!  With continued treatments, improvements can be maintained, and last longer when combined with a balanced diet and regular exercise.  For men, the procedure can significantly reduce unwanted body fat on the chest (gynecomastia) that results from hormonal changes, certain medical conditions or from remaining fat after weight loss.

The procedure also evens out the skin, making it smoother and tighter, and reduces skin irregularities.  Unwanted cellulite, stretch marks and sagging skin under the neck can all be targeted effectively.  This non-invasive, virtually pain-free treatment is well tolerated by patients and is popular among both male and female patients.

 




Blog

Twitter